Suzhou Lixin Pharmaceutical
Suzhou, Jiangsu, China
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: Suzhou Lixin Pharmaceutical
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Suzhou, Jiangsu, China
- Website
- https://lixinpharm.com/peijian
- Modalities
- Small Molecule API, Intermediates, Custom Synthesis
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Suzhou Lixin Pharmaceutical
Suzhou Lixin Pharmaceutical makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Custom Synthesis. 1 manufacturing site registered with the U.S. FDA. Website: https://lixinpharm.com/peijian
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Suzhou Lixin Pharmaceutical FDA Inspection History
2023-08
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2023-08-30 |
Suzhou Lixin Pharmaceutical Co. Ltd.
Suzhou
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Suzhou Lixin Pharmaceutical
How many FDA inspections does Suzhou Lixin Pharmaceutical have on record?
CDMO Signal tracks 1 FDA inspection for Suzhou Lixin Pharmaceutical, sourced from the FDA inspection database. See the full inspection history above.
Has Suzhou Lixin Pharmaceutical received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Suzhou Lixin Pharmaceutical.
Does Suzhou Lixin Pharmaceutical have a CDMO Signal Score?
Not yet. Suzhou Lixin Pharmaceutical is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Suzhou Lixin Pharmaceutical for a manufacturing program?
Use the free AI matchmaker to compare Suzhou Lixin Pharmaceutical against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Jiangxi Fushine Pharmaceutical
Jingdezhen, Jiangxi, China
Small Molecule API, Intermediates, Custom Synthesis
Zenji Pharmaceuticals
Huai'an, Jiangsu, China
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose
Zhejiang Yongtai Technology
Linhai, Zhejiang, China
Intermediates, Small Molecule API, Custom Synthesis
Zhejiang Tianyu Pharmaceutical
Taizhou, Zhejiang, China
Small Molecule API, Intermediates, Custom Synthesis, High-Potency APIs, Spray Drying
Raffles PharmaTech
Huizhou, Guangdong, China
Small Molecule API, Intermediates, Lipids, Oligonucleotide, Custom Synthesis
Compare Suzhou Lixin Pharmaceutical with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.